High-dose LT-02 meets ulcerative colitis endpoint

Lipid Therapeutics GmbH (Heidelberg, Germany) said high-dose LT-02 given four times per day met the primary

Read the full 167 word article

How to gain access

Continue reading with a
two-week free trial.